09:20 SINO BIOPHARM<01177> - Results Announcement (1) Sino Biopharmaceutical Limited announced on 30/03/2005: (stock code: 01177 ) Year end date: 31/12/2004 Currency: HKD Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/01/2004 from 01/01/2003 to 31/12/2004 to 31/12/2003 Note ('000 ) ('000 ) Turnover : 1,050,383 821,700 Profit/(Loss) from Operations : 265,828 167,470 Finance cost : (1,348) (1,380) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : 54,985 7,411 Profit/(Loss) after Tax & MI : 168,337 81,615 % Change over Last Period : +106.3 % EPS/(LPS)-Basic (in dollars) : 0.1263 0.0615 -Diluted (in dollars) : 0.1162 0.0558 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 168,337 81,615 Final Dividend : 4 cents 10 cents per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : 10/05/2005 to 13/05/2005 bdi. Payable Date : 31/05/2005 B/C Dates for Annual General Meeting : 10/05/2005 to 13/05/2005 bdi. Other Distribution for : Bonus issue of 1 share for every 2 Current Period existing shares B/C Dates for Other Distribution : 10/05/2005 to 13/05/2005 bdi. Remarks: (1) Basis of consolidation The consolidated financial statements include the financial statements of the Company and its subsidiaries for the year. The results of subsidiaries acquired or disposed of during the year are consolidated from or to their effective dates of acquisition or disposal, respectively. All significant intercompany transactions and balances within the Group are eliminated on consolidation. The Group's financial statements have been prepared in accordance with Hong Kong Financial Reporting Standards (which also include Statements of Standard Accounting Practice and Interpretations) issued by the Hong Kong Institute of Certified Public Accountants, accounting principles generally accepted in Hong Kong and the disclosure requirements of the Hong Kong Companies Ordinance. They have been prepared under the historical cost convention, except for the periodic remeasurement of certain fixed assets. The Hong Kong Institute of Certified Public Accountants has issued a number of new Hong Kong Financial Reporting Standards and Hong Kong Accounting Standards ("new HKFRSs") which are generally effective for accounting periods beginning on or after 1 January, 2005. The Group has not early adopted these new HKFRSs in the financial statements for the year ended 31 December, 2004. The new HKFRS may result in changes in the future as to how the Group's financial performance and financial position are prepared and presented. During the year, the Group consistently applied the accounting policies stated in the financial statements for the year ended 31 December, 2004.